Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares changing hands.
Polydex Pharmaceuticals Stock Performance
The company has a 50-day simple moving average of $1.99 and a 200-day simple moving average of $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Limited is a Canadian pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company’s operations have included products for both human and veterinary applications, with activities spanning pharmaceutical ingredients and finished dosage products.
Its product portfolio has included medicines and pharmaceutical chemicals used in areas such as anti-infective, antiseptic, analgesic, anesthetic and antihistamine treatments.
Recommended Stories
- Five stocks we like better than Polydex Pharmaceuticals
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
- Why Wall Street Expects Even More From SanDisk After Its 575% Rally
- The Grocery Shelf Battle Is Changing—Who Comes Out Ahead?
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
